As of Tuesday, February 24, Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 7.18%, which has investors ...

THE WOODLANDS, Texas, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company has made the strategic decision to eliminate its commercial ...

Lexicon Fabricators and Constructors is expanding operations and adding 130 employees with the purchase of a north Louisiana steel producer. The Little Rock company announced Tuesday that it has ...

LITTLE ROCK (KATV) — A major steel fabrication and construction company is investing $37.6 million to expand their headquarters and operations in Little Rock, the Arkansas Economic Development ...

Lexicon reported a net loss of $53.4 million in Q2 2024, with revenues of $1.6 million, primarily from sales of INPEFA, the marketed form of sotagliflozin. The company is also preparing for an FDA ...

THE WOODLANDS, Texas - Lexicon Pharmaceuticals , Inc. (NASDAQ:LXRX), a biopharmaceutical company, announced today a significant restructuring plan that includes the elimination of its commercial ...

THE WOODLANDS, Texas - Lexicon Pharmaceuticals , Inc. (NASDAQ: NASDAQ:LXRX) announced today that Ivan H. Cheung has joined its Board of Directors. Cheung, with over 25 years in the healthcare industry ...

Shares of small-cap biotech Lexicon Pharmaceuticals (LXRX 2.96%) fell by nearly 15% during the first four days of trading this week, according to data provided by S&P Global Market Intelligence. The ...

Lexicon Fabricators and Constructors is expanding operations and adding 130 employees with the purchase of a north Louisiana steel producer. The Little Rock company announced Tuesday that it has ...